OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia
Natalie Kwok Wing Cheuk, Wing Tse, Harry Kam Hung Tsui, et al.
Schizophrenia Research (2023) Vol. 268, pp. 205-222
Closed Access | Times Cited: 9
Natalie Kwok Wing Cheuk, Wing Tse, Harry Kam Hung Tsui, et al.
Schizophrenia Research (2023) Vol. 268, pp. 205-222
Closed Access | Times Cited: 9
Showing 9 citing articles:
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Treatment of pharmacoresistant states in psychiatry - Part 1: Treatment-resistant schizophrenia
Eva Češková
Psychiatrie pro praxi (2025) Vol. 26, Iss. 1, pp. 10-14
Closed Access
Eva Češková
Psychiatrie pro praxi (2025) Vol. 26, Iss. 1, pp. 10-14
Closed Access
Promoting safer and wider worldwide use of clozapine
José de León
Schizophrenia Research (2024)
Closed Access | Times Cited: 3
José de León
Schizophrenia Research (2024)
Closed Access | Times Cited: 3
Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition
Yanhui Li, Mei San Ang, Jie Yin Yee, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Yanhui Li, Mei San Ang, Jie Yin Yee, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Factors associated with cognitive dysfunction in treatment-responsive and -resistant schizophrenia: A pilot cross-sectional study
Yuhei Suzuki, Kenya Watanabe, Keiko Kanno‐Nozaki, et al.
Journal of Psychiatric Research (2024) Vol. 178, pp. 228-235
Closed Access | Times Cited: 1
Yuhei Suzuki, Kenya Watanabe, Keiko Kanno‐Nozaki, et al.
Journal of Psychiatric Research (2024) Vol. 178, pp. 228-235
Closed Access | Times Cited: 1
The relationship of cardiovascular disease risk, clozapine antipsychotic use and cognitive function in a large Chinese schizophrenia cohort
Chenghao Lu, Xiaoying Jin, Nannan Liu, et al.
Brain Research (2024) Vol. 1845, pp. 149220-149220
Closed Access | Times Cited: 1
Chenghao Lu, Xiaoying Jin, Nannan Liu, et al.
Brain Research (2024) Vol. 1845, pp. 149220-149220
Closed Access | Times Cited: 1
Modeling the effects of treatment resistance and anticholinergic burden on cognitive function domains in patients with schizophrenia
Sherry Kit Wa Chan, Tiffanie Sze Wing Pang, Harry Kam Hung Tsui, et al.
Psychiatry Research (2024) Vol. 337, pp. 115985-115985
Closed Access
Sherry Kit Wa Chan, Tiffanie Sze Wing Pang, Harry Kam Hung Tsui, et al.
Psychiatry Research (2024) Vol. 337, pp. 115985-115985
Closed Access
Clozapine/norclozapine plasma level ratio and cognitive functioning in patients with schizophrenia spectrum disorders: a systematic review
Timo T. Moscou, Selene Veerman
Therapeutic Advances in Psychopharmacology (2024) Vol. 14
Open Access
Timo T. Moscou, Selene Veerman
Therapeutic Advances in Psychopharmacology (2024) Vol. 14
Open Access
